Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A3 pseudogene 13 (HNRNPA3P13)

Target
HNRNPA3P13
Molecular classification
Other
01

Overview

Heterogeneous nuclear ribonucleoprotein A3 pseudogene 13 (HNRNPA3P13) is a processed pseudogene—a non-functional duplicate—of the HNRNPA3 gene, located in the human genome[3][7][8]. Pseudogenes like HNRNPA3P13 do not produce functional proteins and do not have characterized biological functions, disease relevance, or drug interactions[5]. The canonical protein, heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3), is a member of the hnRNP A/B RNA-binding protein family involved in pre-mRNA processing and has documented links to cancer biology and cellular processes[2][4][6]. However, HNRNPA3P13 itself is not a receptor, enzyme, or other molecular target of therapeutic interest; it is simply one of many pseudogenic copies in the genome, with no evidence of protein-coding or direct biological activity[5][3][7][8]. Assessment: - HNRNPA3P13 is a pseudogene, not a functional molecular target, and therefore not relevant for drug targeting or biomarker purposes[5][3][7][8]. - This entry is incorrect for most drug discovery or therapeutic contexts where "target" refers to a functional protein, receptor, enzyme, or other biomolecule of interest—unless specifically studying pseudogene regulation or evolutionary genomics. - For information related to molecular targets, the functional gene HNRNPA3, not its pseudogenes, should be considered.

Other names
HNRNPA3P13heterogeneous nuclear ribonucleoprotein A3 pseudogene 13[3][7][8]

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 13 (HNRNPA3P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 13 (HNRNPA3P13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call